Marijuana Addiction

Cannabis use disorder involves difficulty controlling marijuana use despite harm. Learn the signs, withdrawal symptoms, treatment options, and ways to get support.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

Understanding Marijuana Addiction

Cannabis may still help you relax while taking more time, money, or attention than you want. Perhaps cutting back has been difficult. Cannabis use disorder is a pattern of cannabis use that causes significant distress or problems in daily life.[1]

Using cannabis, being high, needing more for the same effect, and having symptoms after stopping are related but different experiences. None alone establishes cannabis use disorder. Diagnosis considers the broader pattern.[1]

Cannabis Symptoms That Need Urgent Help

Call 911 immediately if someone cannot be awakened, has trouble breathing, collapses, or has a seizure.[2]

Seek urgent medical assessment when someone is heavily intoxicated or unconscious, or has severe or confusing symptoms, especially if other substances may be involved. Other medical or substance-related problems can resemble cannabis intoxication. Information about what was taken, when, how, and in what quantity can help the assessment.[3]

If a child ingests cannabis, contact poison control at 1-800-222-1222, or call 911 if it is an emergency. Children who eat cannabis edibles can become seriously ill or require hospitalization. Eating large amounts of products containing delta-8 THC, a form of THC, has also led to medical emergencies, including among children.[4][1]

Fast Facts About Cannabis Use Disorder
  • Control and consequences matter. Diagnosis considers symptoms and their effect on daily life.[1]
  • Withdrawal can make stopping difficult. Sleep, mood, and appetite changes can follow stopping cannabis.[3]
  • Behavioral treatment can help. Counseling approaches are the main established treatments.[3]

What Cannabis Products Contain

Cannabis, often called marijuana, refers to products derived from the cannabis plant. These products vary substantially in their ingredients, strength, and method of use. Someone might smoke or vaporize plant material, eat an edible, use a concentrated extract, or take a regulated prescription cannabinoid medicine.[1]

Cannabinoids are compounds such as THC and CBD found in cannabis, or manufactured versions used in medicines. These products should not be treated as interchangeable.[1]

Tetrahydrocannabinol, usually called THC, is the principal cannabis component associated with intoxication or feeling “high.” Potency means the concentration of THC in a product. Higher-potency products expose a person to more THC for a given amount of product, although actual exposure also depends on how much is used and how it is taken.[5]

Cannabidiol, or CBD, is another cannabis-derived compound. It does not produce the euphoria, or feeling of being high, associated with THC and has low abuse or dependence potential, meaning a low likelihood of problematic use or becoming dependent on it.[3]

However, commercial CBD products and a Food and Drug Administration (FDA)-approved, plant-derived CBD medication are different formulations with different evidence and intended uses.[3][1]

Cannabis effects vary with the dose, THC potency, other ingredients, how the product is taken, use of other drugs, underlying health conditions, age, sex, genetic differences, and previous cannabis experience.[1] A label saying “cannabis,” “THC,” or “CBD” therefore does not tell the whole story about likely effects or risk.

How Cannabis-Related Terms Differ

The distinctions below can help someone describe what is happening without assuming a diagnosis.

How cannabis use, intoxication, tolerance, withdrawal, and use disorder differ
Term What It Means What It Does Not Establish
Cannabis use Taking a cannabis or cannabinoid product It does not by itself mean intoxication or a disorder.
Intoxication Temporary mental or physical effects occurring after use, such as altered time perception or impaired memory and movement It does not by itself establish a persistent disorder.[1]
Tolerance Needing more cannabis to obtain the desired effect It is one possible diagnostic symptom, not a complete diagnosis by itself.[1]
Withdrawal Symptoms occurring after stopping cannabis use It can count toward diagnosis, but one symptom alone does not establish cannabis use disorder.[1]
Cannabis use disorder A pattern causing significant distress or impairment, with at least two defined symptoms during 12 months It cannot be determined solely by whether a person uses cannabis or has a positive drug test.[1][3]

When discussing withdrawal, the practical question is whether symptoms occur after stopping cannabis use. Such symptoms need assessment because other substance withdrawal and mental health conditions can look similar. Physical dependence is distinct from the broader pattern of impaired control, risky use, and harm assessed for cannabis use disorder. Withdrawal is only one possible diagnostic symptom.[1][3]

A person can experience cannabis intoxication without meeting cannabis use disorder criteria. Conversely, tolerance or withdrawal symptoms are individual diagnostic symptoms, so a clinician still needs to assess whether the complete diagnostic standard is met.[1]

Cannabis Use Patterns and Population Estimates

In the United States, an estimated 61.59 million people age 12 or older (21.2%) used marijuana in the past year, according to the 2025 National Survey on Drug Use and Health.[6][7] The survey estimated that 19.338 million (6.7%) had past-year cannabis use disorder.[6][7] Use and a use disorder are different measures.[6][7]

Cannabis use ranges from isolated or occasional use to frequent, heavy use. Frequency matters because every-day or almost-every-day use of THC-containing products is associated with developing cannabis use disorder, and frequency is described as its strongest predictor. Duration of use and a family history of drug use may also contribute.[1]

Studies cited by the National Institute on Drug Abuse have estimated that 22% to 30% of people who use cannabis have cannabis use disorder.[1] This range is not a personal probability for every person who has ever used cannabis.

Risk differs with frequency, product potency, duration, and other individual factors such as family history. Cannabis effects may also vary by age.[1][5]

A medical reason for cannabis use does not make impaired control or adverse effects irrelevant. Cannabis use disorder is defined by a pattern of clinically significant impairment or distress. Assessment considers the pattern and its consequences, including unsuccessful attempts to cut down, neglected responsibilities, and continued use despite problems.[1]

Why Estimates Differ

A population estimate only makes sense when its definitions and timeframe are clear. “Ever used cannabis,” “used in the past month,” daily use, physical dependence, and past-year cannabis use disorder measure different things.

The diagnostic system also matters. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, called DSM-5, combines former abuse and dependence categories into cannabis use disorder and grades severity by symptom count. The International Classification of Diseases, 11th Revision, or ICD-11, instead distinguishes hazardous use, a harmful pattern, and cannabis dependence.[3]

Population estimates depend on the country, sampling method, and definitions used. The 2025 NSDUH estimates describe people age 12 or older in the U.S. civilian, noninstitutionalized population. They should not be treated as estimates for institutionalized people, other countries, or an individual person’s chance of developing a disorder.[6][7]

Dates are important because products and use patterns change. A systematic review noted that cannabis potency has increased internationally.[5] Estimates from earlier periods may therefore describe exposure to a different product market than estimates collected after high-potency concentrates became more available.

Why Potency Is Difficult to Measure

Many studies measure how often someone uses cannabis but do not adequately measure the amount of THC consumed. The growing variety of products and methods of use makes comparisons harder. Researchers have proposed a standard THC unit of 5 milligrams to compare exposure in studies. This is a research measure, not a recommended or risk-free dose. Reliable, economical measurement outside laboratory settings remains challenging.[3]

This limitation affects risk estimates and treatment research. Two people described as daily users may consume very different amounts of THC. One may use lower-potency plant material, while another uses a concentrated product. Frequency remains useful, but it is not a complete measure of exposure.

Signs of Marijuana Addiction and How It Is Diagnosed

Reasons to request an assessment include slipping control, use that creates risk, or cannabis interfering with health, responsibilities, relationships, or valued activities, not simply the fact that cannabis has been used.[1]

Under DSM-5, a clinician diagnoses cannabis use disorder when at least two of 11 symptoms have produced clinically significant distress or impairment within a 12-month period. Mild disorder involves two or three symptoms, moderate disorder four or five, and severe disorder six or more.[1]

Signs of Impaired Control

Impaired control can appear in several ways:

  • Using more cannabis, or using it for longer, than intended
  • Wanting to reduce or stop but repeatedly being unable to do so
  • Spending substantial time obtaining cannabis, using it, or recovering from its effects
  • Experiencing craving, meaning a strong desire or urge to use

These signs focus on what happens around use, not merely how often it occurs.[1] Frequency is an important risk marker, but diagnosis depends on consequences and the broader symptom pattern.

Signs of Harm or Risk

Other diagnostic symptoms concern the effects of cannabis on everyday life:

  • Continuing to use despite problems at work, school, or home
  • Continuing despite social or relationship problems
  • Giving up important hobbies, social activities, or work-related activities
  • Using in situations where impairment creates a risk of injury
  • Continuing despite knowing that cannabis has caused or worsened a physical or psychological problem

Tolerance and withdrawal are the remaining diagnostic symptoms.[1] Neither should be viewed in isolation from the person’s overall experience.

What Loss of Control Can Look Like

For example, imagine an adult who uses cannabis most evenings. Frequency alone does not diagnose cannabis use disorder. If the person repeatedly uses more than planned, cannot follow through on efforts to cut back, and continues despite worsening conflict at home, those are three possible criteria within the impaired-control and harm domains.

A clinician would still confirm the timeframe, distress or impairment, and other explanations.

What Screening Questionnaires Can Establish

A screening questionnaire is a brief set of standardized questions intended to identify people who may need a fuller assessment. It can organize a conversation about frequency, control, consequences, and dependence symptoms.

A French literature review identified several brief cannabis-specific tools, including the Cannabis Use Disorders Identification Test–Revised, or CUDIT-R. The review emphasized that questionnaires do not replace clinical diagnosis and should be followed by an appropriate evaluation.[8]

A high score therefore means “look more closely,” not “the diagnosis is proven.” A low score also needs context when there are concerns about intoxicated driving, pregnancy, adolescent use, severe mental health symptoms, or inaccurate reporting.

What a Drug Test Can Establish

A biological test may support that exposure occurred, but exposure is not the same as intoxication, physical dependence, or cannabis use disorder. Context also matters because secondhand cannabis smoke can produce detectable THC in blood or positive urine findings in some environments, including among children.[1]

Diagnosis instead requires a conversation about timing, products, route, quantity, attempts to change, withdrawal, and effects on life. Co-occurring medical or psychiatric conditions and other substances also need consideration because they may cause similar symptoms.[3]

Cannabis Intoxication and Immediate Effects

How long cannabis effects last depends partly on how it is taken, the amount used, and the person. Edibles can take longer to produce effects than inhaled cannabis, which makes taking more too soon risky.[1][4]

Cannabis intoxication is the temporary state produced after use. It may involve relaxation or happiness, altered perception of time, and impaired thinking, memory, or movement. Some people instead feel irritable or restless.[1]

Anxiety, fear, distrust, panic, and hallucinations (seeing or hearing things that others do not) are more likely after a large amount, with a high-THC product, or in someone with little cannabis experience.[1][9] Reported physical effects include increased appetite and elevated heart rate, while respiratory effects depend partly on how the product is used.[1]

Cannabis intoxication can also impair coordination and reaction time and may cause confusion, nausea, vomiting, distorted perception, agitation, or anxiety.[3] These effects can overlap with other drug effects, withdrawal states, or health emergencies, so an unexpected or severe presentation should not automatically be attributed to cannabis.

When Immediate Help Is Appropriate

Cannabis-related heart and circulation symptoms, digestive symptoms, and symptoms involving loss of contact with reality have been reported. Assessment is important rather than assuming cannabis is the only cause.[3]

Cannabinoid hyperemesis syndrome can cause repeated nausea, vomiting, and abdominal pain after long-term, heavy cannabis use. Recurring vomiting needs medical assessment. Do not assume that cannabis is the only possible cause.[1]

For suicidal crisis or emotional distress in the United States, call or text 988 to reach the Suicide & Crisis Lifeline.[10]

Cannabis Withdrawal and Physical Dependence

Cannabis withdrawal refers to symptoms that can occur after stopping cannabis use. It differs from intoxication: intoxication follows use, while withdrawal follows stopping. The timing and symptom pattern help a clinician distinguish these experiences from one another and from other health problems.[1][3]

Withdrawal is one possible DSM-5 symptom of cannabis use disorder, but it does not establish the full diagnosis by itself.[1] Likewise, someone can have cannabis use disorder because of impaired control and harm without withdrawal being the main concern.

Cannabis Withdrawal Symptoms and Time Course

The clinical review Cannabis Use and Cannabis Use Disorder reports that withdrawal symptoms typically begin 24–48 hours after stopping, peak within the first week, and last one to two weeks. These are typical ranges, not a promise that every symptom will start or end on a particular day.[3]

The review describes the following symptom groups used in diagnosing cannabis withdrawal:[3]

  • Irritability, anger, or aggression
  • Nervousness or anxiety
  • Sleep difficulties, such as trouble sleeping or disturbing dreams
  • Decreased appetite or weight loss
  • Restlessness
  • Depressed mood
  • Physical symptoms causing severe discomfort, such as abdominal pain, shakiness or tremors, sweating, fever, chills, or headache

A clinical diagnosis of cannabis withdrawal considers the symptom pattern, timing after stopping, and whether symptoms cause serious distress or interfere with social life, work, or other important activities. This withdrawal diagnosis is distinct from the broader cannabis use disorder diagnosis.[3]

The symptoms are not unique to cannabis withdrawal. Similar problems can occur with withdrawal from other substances or with mental health conditions. Matching symptoms to the timing of cannabis use is therefore more useful than treating a checklist as proof.[3]

Distinguishing Withdrawal From Another Problem

Timing provides an important clue. An assessment should ask when cannabis was last used, when the amount used changed, what product and route were involved, how much was used, and whether alcohol or other drugs were also taken.[3]

Symptoms should not automatically be labeled withdrawal if they are severe, unusual, worsening, or inconsistent with the exposure history. Intoxication, another substance’s effects, a medical illness, and psychiatric conditions may present in similar ways.[3]

In the absence of medical or psychiatric co-occurring conditions, cannabis withdrawal generally does not pose serious risks, and many people require supportive care rather than a medical detoxification procedure.[3] That reassurance does not apply automatically when symptoms could represent another emergency or when important co-occurring conditions are present.

Support During Withdrawal

Behavioral withdrawal care can include education about what to expect and practical coping-skills training. The clinical review describes exercise or hot baths for irritability, avoiding excessive caffeine when restlessness is a problem, eating nutritious food when appetite is low, and remembering that symptoms are temporary.[3]

Ask a clinician whether your symptoms fit the timing of your recent cannabis and other substance use, and which symptoms should prompt another assessment. Education about withdrawal and practical coping skills are supported forms of care. Assessing other possible causes remains important.[3]

Cognition, Driving, and Injury Risk

Cannabis can impair thinking, memory, body movement, coordination, and reaction time during intoxication.[1][3] The amount of impairment varies with the amount used, potency, other substances, underlying medical conditions, and experience.[1]

Research analyses have found increased crash risk after cannabis use, and epidemiological evidence indicates that cannabis makes a small contribution to motor vehicle crashes. However, one National Highway Traffic Safety Administration study did not find a significant increase in crash risk attributable to cannabis use.[1][3]

These findings do not establish that cannabis and driving are safe. A study’s failure to demonstrate an attributable increase is not proof of equivalence between driving after cannabis and driving without it. The direct evidence of impaired thinking, movement, and reaction time supports avoiding driving while affected.[3][1]

Other substances and medicines belong in the assessment too. NIDA notes that cannabis effects depend partly on other drugs taken and a person’s underlying medical conditions. Tell the clinician about all products you use when discussing impairment, symptoms, and possible interactions.[1]

Respiratory and Secondhand-Smoke Effects

Smoking cannabis exposes the respiratory system to smoke. Regular cannabis smoking is reliably associated with chronic bronchitis (long-lasting inflammation of the airways) even after researchers account for tobacco smoking.[3] An association does not show that every person who smokes cannabis will develop bronchitis, but persistent cough or other respiratory symptoms warrant discussion with a healthcare professional.

Secondhand cannabis smoke contains many of the same toxins, irritants, and cancer-causing substances as secondhand tobacco smoke. Exposure can sometimes result in detectable THC or positive drug tests in some environments.[1]

Reports have also documented positive urine tests in children exposed to cannabis smoke in their own or attached homes, with exposure linked to respiratory infections.[1] Keeping smoke away from children and other people reduces involuntary exposure.

These findings concern smoked products. They should not be automatically assigned to non-smoked formulations. At the same time, avoiding smoke does not remove risks related to THC intoxication, high potency, accidental ingestion, impaired driving, or cannabis use disorder.

Mental Health and Cannabis

Cannabis use and mental health conditions often occur together, but co-occurrence does not by itself establish which came first or whether one caused the other. Symptoms may precede cannabis use, follow it, share other causes, or influence one another.

In a national Australian sample, 7 in 10 adults with cannabis use disorder had another psychiatric disorder, compared with 4 in 10 cannabis users without the disorder and 1.5 in 10 people who did not use cannabis.[3]

U.S. surveys also found strong associations between past-year cannabis use disorder and mood, anxiety, post-traumatic stress, and personality disorders.[3]

These population findings support assessment for both cannabis-related problems and mental health conditions. They do not prove that cannabis caused each co-occurring disorder.

Psychosis and Potency

Psychosis involves losing contact with reality and may include hallucinations, delusions (strongly held false beliefs), or severely disorganized thinking.[9] Acute cannabis effects can include hallucinations or psychotic symptoms, particularly with high THC exposure.[1][3]

A systematic review screened 4,171 articles and included 20 observational studies.[5] Higher-potency cannabis, compared with lower-potency cannabis as defined by each study, was associated with increased risks of psychosis and cannabis use disorder. Evidence was inconsistent for depression and anxiety.[5]

Because these were observational studies, the review establishes associations rather than proving that potency caused every outcome. The researchers called for standardized exposure measures and stronger longitudinal studies that follow people over time.[5]

Depression and Anxiety

Acute cannabis use can produce anxiety, panic, agitation, or depressed feelings.[1][3] Longer-term observational findings are more difficult to interpret because people may use cannabis in response to pre-existing distress, and shared social or health factors may influence both cannabis use and mental health.

Severe confusion, hallucinations, agitation, anxiety, or other intoxication-like symptoms need direct assessment because other medical emergencies can present similarly. An important part of that assessment is establishing which substances were used, when, how they were taken, and in what quantity.[3]

Adolescents and Young Adults

Adolescent cannabis use deserves particular attention even when the young person does not meet the full threshold for cannabis use disorder. Development, cognitive and school functioning, transportation safety, co-occurring mental health symptoms, and product potency are relevant concerns.[11][12][5]

A study of U.S. adolescents ages 12 to 17 used 2015–2019 National Survey on Drug Use and Health data. It estimated that 2.5 million adolescents had nondisordered cannabis use, meaning use below the DSM-5 threshold for cannabis use disorder.[11]

Compared with nonuse, both nondisordered use and cannabis use disorder were associated with adverse psychosocial outcomes. Adolescents in these cannabis-use groups were approximately two to three times as likely to report cognitive difficulties involving executive control, attention, or episodic memory. Executive control includes planning, decision-making, and regulating behavior. Episodic memory means remembering personal experiences and events.[11]

The study was cross-sectional, meaning exposure and outcomes were measured without following individuals forward to establish sequence. It relied on self-report (participants’ own accounts) and could not fully account for psychiatric conditions such as anxiety. The researchers therefore could not establish that cannabis caused the observed outcomes.[11]

The practical message is not that every adolescent who uses cannabis has a disorder. It is that below-threshold use can still serve as a marker for concerns that deserve conversation and assessment.

Youth Screening and Brief Intervention

Primary care offers an opportunity to discuss cannabis, alcohol, and riding with impaired drivers.[12] A young person or caregiver can ask the practice how privacy is handled and whether part of the visit can take place without a caregiver present.

In the pilot trial of 965 youths ages 12 to 18, 869 completed baseline assessment and 211 reported recent alcohol or cannabis use. Among those already at risk, computer-facilitated screening plus clinician counseling delayed first cannabis use after the visit compared with usual care and reduced reported riding with an impaired driver at 12 months.[12]

In this pilot study conducted in five pediatric practices, screening was paired with brief clinician counseling, and practitioners received recommended follow-up plans. Larger studies are needed to test the approach in more settings.[12]

Pregnancy, Breastfeeding, and Children

Cannabis use during pregnancy has been linked with lower birth weight, preterm birth, hospitalization, death within the first year, and other adverse outcomes.[1] These are associations, and continuing research is intended to clarify how prenatal exposure and related factors affect development.

The American College of Obstetricians and Gynecologists recommends counseling against cannabis use while trying to become pregnant, during pregnancy, and while breastfeeding because of potential effects on the developing brain.[1] Someone using cannabis for symptoms should discuss cannabis use and symptom management with a pregnancy-care clinician.

The Centers for Disease Control and Prevention recommends keeping cannabis products in a locked childproof container, out of children’s reach and sight. Some edibles resemble familiar candy or snacks. Accidental ingestion can cause serious illness and hospitalization.[4][1]

Perceived Benefits and Medical Uses

People may experience cannabis as relaxing or pleasurable, and cannabinoids have been studied for symptom relief.[1] Perceived benefit is important to discuss because it may be genuine for the individual, but it does not establish that a product is effective, safe, or appropriate for a medical condition.

Medical evidence differs by compound, formulation, dose, and indication. Evidence for a standardized prescription medicine cannot automatically be transferred to smoked cannabis, a dispensary edible, a high-potency concentrate, or a CBD product that was not the studied prescription medicine.[1]

FDA-Approved Cannabinoid Medicines

The U.S. Food and Drug Administration has not approved whole cannabis plant material for any medical purpose. It has approved specific cannabinoid medicines for limited indications.[1]

FDA-approved cannabinoid medicines and their specific uses
Medicine Or Product Supported FDA-Approved Use
Dronabinol and nabilone Nausea and vomiting associated with cancer chemotherapy
Dronabinol Anorexia, meaning loss of appetite here, and weight loss associated with human immunodeficiency virus and acquired immunodeficiency syndrome, or HIV/AIDS
A plant-derived CBD medicine Seizures associated with certain rare forms of epilepsy

These approvals apply to particular medicines and uses, not to cannabis products as a whole.[1]

Conditions With Limited or Uncertain Evidence

There is evidence that cannabis may help some forms of pain, and research continues into other therapeutic uses. NIDA also notes that the FDA has not approved a product containing whole cannabis plant material for any purpose. Discuss a particular symptom and product with a clinician instead of assuming that every cannabis product has the same evidence.[1]

These statements are not contradictory. “Some forms of pain” is narrower than “pain” generally, and evidence may differ by condition, product, preparation, and indication. Potential benefit may also be outweighed by adverse effects for some people.[1]

Before using cannabis or cannabinoids for a medical condition, discuss the specific formulation, evidence, other medicines, underlying conditions, and any signs of problematic use with a healthcare professional. NIDA emphasizes consulting a doctor before consuming these products to treat a condition.[1]

Marijuana Addiction Treatment and Help Cutting Back

A person does not need to wait for severe consequences before asking for help. Appropriate goals may include stopping, reducing use, avoiding high-risk situations, understanding whether symptoms are withdrawal, or deciding whether a medical claim is supported.

A cannabis-focused assessment can address the following information about exposure, symptoms, and effects on daily life:[1][3]

  • Products, potency, route, frequency, and typical amount
  • Cravings, tolerance, intoxication, and withdrawal
  • Attempts to reduce or stop
  • Effects on work, school, relationships, health, valued activities, and safety
  • Alcohol and other substance use
  • Co-occurring mental or physical health conditions

This information helps distinguish use, intoxication, withdrawal, and cannabis use disorder, and identify other possible explanations for symptoms.[1][3] You can also bring your own questions: What would you like to change? What feels difficult about changing? What type of help would you consider?

Behavioral Approaches to Marijuana Addiction Treatment

Behavioral treatment is the best-supported active treatment for cannabis use disorder. First-line approaches for adolescents and adults include cognitive behavioral therapy (CBT), motivational enhancement therapy (MET), and contingency management, often in combination. These are psychosocial treatments: care based on psychological and behavioral support rather than medication.[3]

Cognitive behavioral therapy helps people recognize patterns around cannabis use and practice skills for coping with cravings, stress, and difficult moods. Motivational enhancement therapy helps people explore their reasons for changing and strengthen their commitment to a goal. A therapist uses discussion and feedback rather than confrontation.[13]

To understand what a particular program offers, ask what a typical session involves, which skills you would practice between visits, and how progress is reviewed.

Contingency management offers concrete rewards for meeting agreed treatment goals, such as urine tests showing no cannabis use. Abstinence means not using cannabis. Evidence supports adding these incentives to other behavioral care in some settings.[14]

How Much Can Behavioral Treatment Help?

A 2016 Cochrane systematic review, which brings together and evaluates research on a defined question, included 23 trials that randomly assigned 4,045 adults to treatment groups in outpatient or community settings.[14] At a median follow-up of four months, people receiving psychosocial treatment used cannabis on about six fewer days in the past 30 days than those receiving minimal or inactive care.[14]

Participants receiving treatment were also more likely to report abstinence and fewer dependence symptoms and cannabis-related problems, although evidence quality varied by outcome. About seven in ten completed treatment as intended.[14]

The Cochrane review found that combined MET and CBT was among the most consistently supported approaches. Its treatment comparisons describe groups studied in particular settings. They do not guarantee an individual outcome.[14]

In the Cochrane review, interventions involving more than four sessions over longer than one month had more consistent short-term benefits than less intensive approaches. The authors could not identify an ideal number of sessions or treatment duration. Ask how a proposed program’s length and follow-up fit your circumstances.[14]

In that 2016 review, treatment gains often weakened over time. No specific psychosocial intervention was consistently effective at nine months or later, and roughly one-quarter of participants were not using cannabis at final follow-up.[14] Continuing support and learning from setbacks may therefore be more realistic than expecting one brief episode of care to settle every concern.

A 2025 review included 22 randomized trials with 3,304 participants ages 16 and older.[15] Combined motivational enhancement therapy and cognitive behavioral therapy may help people stop using cannabis at the end of treatment compared with inactive care or support that did not provide a specific cannabis treatment. However, fewer completed treatment in that comparison. The reviewers rated the evidence low to very low certainty, so the size and reliability of the benefits remain uncertain.[15]

Ask What “Success” Means

Researcher Monika Halicka and colleagues point out that cannabis treatment studies do not yet share an agreed set of outcomes. Even studies measuring continuous abstinence used different periods, and it is unclear how much change in some measures is meaningful to patients.[15]

That distinction matters when a program advertises a success rate. Ask whether it means completing sessions, reducing use, not using cannabis for a stated period, or improving daily life. Ask when the result was measured and whether people who left treatment were included.

The 2021 clinical review found insufficient adult evidence to recommend group over individual treatment or telephone and internet delivery over in-person care.[3] This does not prove the formats are equivalent. When choosing care, discuss your preferences, privacy, access, and what the program actually provides.

Medications for Cannabis Use Disorder

There is currently no FDA-approved medication for cannabis use disorder or medically assisted cannabis withdrawal.[1] Medications may still be used for a separate diagnosed condition, but that is different from having an approved medicine that treats cannabis use disorder itself.

Medication Decisions

This evidence does not support self-treating cannabis use disorder with prescription drugs, supplements, THC, or CBD. A clinician can instead address co-occurring conditions, monitor withdrawal, and connect medication decisions to their approved or evidence-supported purposes.

A 2025 Cochrane review included 37 medication trials with 3,201 participants.[16] Most participants were adults, and four studies focused on adolescents or young adults. The authors found that medicines studied for cannabis use disorder should still be considered experimental.[16]

For example, THC preparations did not improve the likelihood of stopping cannabis at the end of treatment compared with placebo (an inactive comparison treatment), with moderate-certainty evidence. Evidence for many other comparisons was more uncertain.[16]

A 2026 analysis comparing medication and psychological treatments also rated its evidence low to very low certainty. It does not establish a reliable medication ranking or an approved drug treatment.[17]

Relief of a withdrawal symptom and lasting recovery are different outcomes. The treatment evidence does not justify treating an experimental medicine as an established cure. NIDA states that no medication is FDA-approved for cannabis use disorder or medically assisted cannabis withdrawal.[3][1]

A clinician can help assess symptoms, co-occurring conditions, and treatment options. Ask what outcome a proposed medicine is intended to improve, what evidence supports it, and how benefits and adverse effects would be monitored. These are questions for an individual care discussion, not a medication regimen.

Family and Supportive Relationships

If you are concerned about someone’s cannabis use, you can start by describing what you have noticed rather than trying to assign a diagnosis. You can also seek support for yourself while the person decides whether to pursue care.

A supportive conversation can focus on specific changes: missed obligations, driving after use, escalating potency, failed efforts to cut back, worsening anxiety, or cannabis replacing valued activities. Ask what the person likes and dislikes about use, whether they have considered a change, and what kind of support would feel acceptable.

Family members can seek support for their own needs while someone else is using substances. A study of female spouses and partners affected by substance use or gambling problems examined how they coped, including self-care, social support, and boundaries. It was not a cannabis-specific treatment trial.[18]

Its findings should not be read as a promise that a particular family response will make someone enter treatment. The useful distinction is between supporting another person and obtaining help for your own stress, health, finances, and safety.[18]

A conversation can start with an observable concern: “You have missed work several times, and I’m worried. Would you be willing to talk with someone about what is happening?”

You can also ask a counselor what support is available for family members and which boundaries fit your circumstances. Your own care does not have to wait until the other person agrees to seek treatment.[18]

Call 911 immediately if someone cannot be awakened, has trouble breathing, collapses, or has a seizure.[2]

Safety priorities include avoiding rides with an impaired driver, protecting children from cannabis exposure, and obtaining medical assessment for heavy intoxication, unconsciousness, or severe or confusing symptoms.[12][1][3] For suspected cannabis poisoning, contact poison control. Call 911 if it is an emergency.[4]

Practical Ways to Lower Risk

Reducing risk is useful whether someone plans to stop now, reduce gradually with professional support, or is still deciding what they want.

The evidence supports several practical priorities:

  • Do not drive while affected, or ride with an impaired driver.[1][12]
  • Discuss other drug use with a clinician. If you use edibles, also mention medications or alcohol used at the same time.[1][4]
  • Treat high-THC products as higher-risk rather than equivalent to lower-potency products.[5]
  • Keep edibles and other cannabis products in a locked childproof container, out of children’s reach and sight.[4]
  • Keep cannabis smoke away from children and other bystanders.[1]
  • Seek assessment if use is becoming more frequent, harder to control, or connected to worsening health or functioning.[1]
  • Discuss pregnancy, breastfeeding, psychosis risk, and underlying medical conditions with a healthcare professional before using cannabis medicinally.[1][5]

These measures reduce particular risks but do not make cannabis use risk-free or treat cannabis use disorder.

Choosing In-Person or Online Care

A primary care clinician can help you begin an assessment and find further support. For local or remote mental health care, the National Institute of Mental Health recommends asking about a provider’s experience, treatment approach, goals, costs, insurance, and whether the fit feels right.[10]

For cannabis-focused care, bring a short list of questions:

  • Do you assess and treat cannabis use disorder, including the products I use?
  • Which counseling approaches do you offer, and how will we decide on goals?
  • How will you assess sleep, anxiety, other substance use, and medical concerns?
  • If appointments are online, can you see patients where I live, and what would require an in-person visit?
  • What are the fees, insurance requirements, privacy arrangements, and options for follow-up?

These questions help you compare services. An online therapy listing alone does not establish that a particular clinician provides cannabis-specific treatment. Ask directly before booking.

Find Help That Fits Your Cannabis Use

If you are simply wondering about your use, begin by recording the product, potency if known, route, frequency, situations around use, and any effects on sleep, mood, memory, responsibilities, relationships, or driving. This can make a healthcare conversation more concrete.

If you have tried unsuccessfully to cut back, experience withdrawal, or keep using despite harm, ask a primary care, behavioral health, or addiction professional for a cannabis-focused assessment.

You can explore therapy options or search the treatment centers directory and ask whether the service offers cannabis treatment. Ask specifically about CBT, MET, contingency management, and support for co-occurring conditions.[1][3]

If you are supporting someone else, describe specific concerns without assigning a diagnosis. Ask about support for affected family members, and protect your own safety and health even if the other person is not ready for treatment.[18]

For an adolescent, arrange a health assessment that covers cannabis, other substance use, transportation safety, mood, attention, and school functioning. Below-threshold use can still identify meaningful risk.[11][12]

During pregnancy, while trying to become pregnant, or while breastfeeding, discuss cannabis use and symptom management with an obstetric or other qualified clinician.[1] If a child ingests cannabis, contact poison control at 1-800-222-1222, or call 911 if it is an emergency.[4]

Call 911 immediately if someone cannot be awakened, has trouble breathing, collapses, or has a seizure.[2]

Seek urgent medical assessment for heavy intoxication, unconsciousness, or severe or confusing symptoms, especially if other substances may be involved. The immediate task is safety and medical assessment, not deciding on the spot whether cannabis is the sole cause.[3]

You do not need to have every answer before asking for help with cannabis use. Explore AddictionHelp’s Treatment Center Directory → and ask programs about cannabis treatment, mental health support, and follow-up.

Prefer to begin with a conversation? You can also explore online therapy options and discuss how cannabis is affecting your daily life.

If you are struggling emotionally or thinking about suicide, call or text 988 for the 988 Suicide & Crisis Lifeline. Call 911 for a life-threatening emergency.[10]

Frequently Asked Questions

Can Someone Have Cannabis Use Disorder Without Using Every Day?

Yes. Frequent use is the strongest identified predictor, but diagnosis is not based on a daily-use rule. Cannabis use disorder means a pattern causing significant distress or problems in daily life. Under the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), at least two qualifying symptoms must occur within 12 months.[1]

Does Tolerance Mean Someone Is Addicted?

Not by itself. Tolerance means needing more cannabis to obtain the desired effect. It is one possible symptom of cannabis use disorder. A clinician considers the full pattern, including difficulty controlling use, consequences, risky situations, and symptoms after stopping. Diagnosis requires at least two qualifying symptoms within 12 months and significant distress or problems in daily life.[1]

Does Withdrawal Prove Cannabis Use Disorder?

No. Withdrawal means symptoms after stopping cannabis use, such as irritability or sleep difficulty. It is one possible diagnostic symptom. Cannabis use disorder requires at least two qualifying symptoms within 12 months and significant distress or problems in daily life. Other substance use and mental or physical health conditions can affect assessment and care.[1][3]

Is CBD the Same As Cannabis With THC?

No. Cannabidiol (CBD) does not produce the high associated with tetrahydrocannabinol (THC) and has low potential for problematic use or dependence. Products vary.[3] A specific U.S. Food and Drug Administration (FDA)-approved CBD medicine for seizures associated with rare forms of epilepsy is not equivalent to unapproved cannabis or cannabinoid products sold for medical purposes or available from dispensaries.[1]

Does Medical Cannabis Use Prevent Cannabis Use Disorder?

No. A medical reason for use does not rule out difficulty controlling use or harm. Assessment still considers significant distress, problems in daily life, unsuccessful attempts to cut back, and continuing use despite consequences.[1]

Is a Positive Cannabis Test a Diagnosis?

No. A blood or urine test can support that cannabis exposure occurred, but it cannot diagnose cannabis use disorder by itself. Diagnosis requires assessment of the symptom pattern over 12 months, significant distress or problems in daily life, and other possible medical, mental health, or substance-related explanations.[3][1]

Are High-Potency Products More Concerning?

Higher potency means a greater concentration of tetrahydrocannabinol (THC), the main component that produces a high. Compared with lower-potency cannabis, higher-potency products have been associated with increased risks of cannabis use disorder and psychosis, which can involve seeing or hearing things that others do not or losing contact with reality.[5][9] The studies were observational, so they show associations without proving that potency alone caused every outcome.

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

18 Sources
  1. National Institute on Drug Abuse. (2024, September 24). Cannabis (marijuana). Read source
  2. National Capital Poison Center. (n.d.). First aid guidelines. Read source
  3. Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021). Cannabis use and cannabis use disorder. Nature Reviews Disease Primers, 7(1), Article 16. Read source
  4. Centers for Disease Control and Prevention. (2024, February 15). Cannabis and poisoning. Read source
  5. Petrilli, K., Ofori, S., Hines, L., Taylor, G., Adams, S., & Freeman, T. P. (2022). Association of cannabis potency with mental ill health and addiction: A systematic review. The Lancet Psychiatry, 9(9), 736–750. Read source
  6. Substance Abuse and Mental Health Services Administration. (2026). 2025 National Survey on Drug Use and Health: Detailed tables (Tables 1.1A–1.1B). Read source
  7. Substance Abuse and Mental Health Services Administration. (2026). 2025 National Survey on Drug Use and Health: Detailed tables (Tables 5.1A–5.1B). Read source
  8. Artigaud, L., Fener, C., Bisch, M., Schwan, R., Schwitzer, T., De Ternay, J., Adamson, S. J., Rolland, B., & Laprévote, V. (2020). [Screening tools for cannabis use disorders and their adaptation to DSM-5: A literature review]. L’Encephale, 46(5), 382–389. Read source
  9. National Institute of Mental Health. (n.d.). Understanding psychosis. Read source
  10. National Institute of Mental Health. (2026, April). Help for mental illnesses. Read source
  11. Sultan, R. S., Zhang, A. W., Olfson, M., Kwizera, M. H., & Levin, F. R. (2023). Nondisordered cannabis use among US adolescents. JAMA Network Open, 6(5), Article e2311294. Read source
  12. Knight, J. R., Sherritt, L., Gibson, E. B., Levinson, J. A., Grubb, L. K., Samuels, R. C., Silva, T., Vernacchio, L., Wornham, W., & Harris, S. K. (2019). Effect of computer-based substance use screening and brief behavioral counseling vs usual care for youths in pediatric primary care: A pilot randomized clinical trial. JAMA Network Open, 2(6), Article e196258. Read source
  13. Winters, K. C., Mader, J., Budney, A. J., Stanger, C., Knapp, A. A., & Walker, D. D. (2021). Interventions for cannabis use disorder. Current Opinion in Psychology, 38, 67–74. Read source
  14. Gates, P. J., Sabioni, P., Copeland, J., Le Foll, B., & Gowing, L. (2016). Psychosocial interventions for cannabis use disorder. Cochrane Database of Systematic Reviews, 2016(5), Article CD005336. Read source
  15. Halicka, M., Parkhouse, T. L., Webster, K., Spiga, F., Hines, L. A., Freeman, T. P., Sanghera, S., Dawson, S., Paterson, C., Savović, J., Higgins, J. P. T., & Caldwell, D. M. (2025). Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta-analysis. Addiction, 120(11), 2181–2201. Read source
  16. Spiga, F., Parkhouse, T., Tang, V. M., Savović, J., Le Foll, B., & Nielsen, S. (2025). Pharmacotherapies for cannabis use disorder. Cochrane Database of Systematic Reviews, 2025(9), Article CD008940. Read source
  17. Halicka, M., Spiga, F., Freeman, T. P., Nielsen, S., Savović, J., Higgins, J. P. T., & Caldwell, D. M. (2026). Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta-analysis. Addiction. Advance online publication. Read source
  18. Petra, M. M. (2020). Coping with a loved one’s substance use disorder or gambling disorder: What strategies really help? Journal of Loss and Trauma, 25(1), 86–98. Read source
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.